Dean Paul Edwards

Dean Paul Edwards's AcademicInfluence.com Rankings

Dean Paul Edwards

Biology

#13389

World Rank

#16934

Historical Rank

Molecular Biology

#2261

World Rank

#2295

Historical Rank

Neuroscience

#2316

World Rank

#2380

Historical Rank

Biochemistry

#2341

World Rank

#2490

Historical Rank

biology Degrees

Download Badge

Biology

Dean Paul Edwards's Degrees

PhD Molecular Biology Stanford University
Bachelors Biochemistry University of California, Berkeley

Why Is Dean Paul Edwards Influential?

(Suggest an Edit or Addition)

(See a Problem?)

Dean Paul Edwards's Published Works

Number of citations in a given year to any of this author's works

Total number of citations to an author for the works they published in a given year. This highlights publication of the most important work(s) by the author

Published Works

Progesterone receptor contains a proline-rich motif that directly interacts with SH3 domains and activates c-Src family tyrosine kinases. (2001) (578)
Regulation of signal transduction pathways by estrogen and progesterone. (2005) (475)
The Steroid Receptor Coactivator-1 Contains Multiple Receptor Interacting and Activation Domains That Cooperatively Enhance the Activation Function 1 (AF1) and AF2 Domains of Steroid Receptors* (1998) (435)
The Opposing Transcriptional Activities of the Two Isoforms of the Human Progesterone Receptor Are Due to Differential Cofactor Binding (2000) (369)
Hormone and antihormone induce distinct conformational changes which are central to steroid receptor activation. (1992) (344)
High-Mobility Group Chromatin Proteins 1 and 2 Functionally Interact with Steroid Hormone Receptors To Enhance Their DNA Binding In Vitro and Transcriptional Activity in Mammalian Cells (1998) (340)
The DNA-bending protein HMG-1 enhances progesterone receptor binding to its target DNA sequences (1994) (210)
Progesterone receptor transcription and non-transcription signaling mechanisms (2003) (208)
The role of extranuclear signaling actions of progesterone receptor in mediating progesterone regulation of gene expression and the cell cycle. (2007) (204)
The progesterone antagonist RU486 acquires agonist activity upon stimulation of cAMP signaling pathways. (1993) (193)
Human sperm plasma membrane progesterone receptor(s) and the acrosome reaction. (1996) (185)
Reduced expression of progesterone receptor-B in the endometrium of women with endometriosis and in cocultures of endometrial cells exposed to 2,3,7,8-tetrachlorodibenzo-p-dioxin. (2005) (162)
Receptor mechanisms mediating non-genomic actions of sex steroids. (2007) (161)
The Role of Coactivators and Corepressors in the Biology and Mechanism of Action of Steroid Hormone Receptors (2000) (158)
Monoclonal antibody identification and characterization of a Mr 43,000 membrane glycoprotein associated with human breast cancer. (1986) (157)
Hormone-dependent interaction between the amino- and carboxyl-terminal domains of progesterone receptor in vitro and in vivo. (1999) (154)
The biology of progesterone receptor in the normal mammary gland and in breast cancer (2012) (151)
Immunologic analysis of human breast cancer progesterone receptors. 1. Immunoaffinity purification of transformed receptors and production of monoclonal antibodies. (1987) (151)
Distribution of an estrogen-induced protein with a molecular weight of 24,000 in normal and malignant human tissues and cells. (1983) (150)
Mechanism of Action of Progesterone Antagonists (2002) (145)
Progesterone Regulates Proliferation of Endothelial Cells* (1999) (141)
Estrogen and progesterone receptor proteins in breast cancer. (1979) (141)
Dimerization of mammalian progesterone receptors occurs in the absence of DNA and is related to the release of the 90-kDa heat shock protein. (1991) (125)
Human progesterone receptor complexed with the antagonist RU 486 binds to hormone response elements in a structurally altered form. (1989) (123)
The constitution of a progesterone response element. (1993) (118)
Estrogen induced synthesis of specific proteins in human breast cancer cells. (1980) (118)
Progesterone Receptor Signaling Mechanisms. (2016) (117)
The role and mechanism of progesterone receptor activation of extra-nuclear signaling pathways in regulating gene transcription and cell cycle progression (2008) (116)
Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancers (2014) (115)
Ligand-Specific Dynamics of the Progesterone Receptor in Living Cells and during Chromatin Remodeling In Vitro (2005) (113)
Monoclonal antibodies against three major glycoproteins of varicella-zoster virus (1983) (111)
Differential hormone-dependent phosphorylation of progesterone receptor A and B forms revealed by a phosphoserine site-specific monoclonal antibody. (2000) (109)
Oncogenic mTOR signaling recruits myeloid-derived suppressor cells to promote tumor initiation (2016) (106)
FOXA1 overexpression mediates endocrine resistance by altering the ER transcriptome and IL-8 expression in ER-positive breast cancer (2016) (106)
Identification of a Phosphorylation Site in the Hinge Region of the Human Progesterone Receptor and Additional Amino-terminal Phosphorylation Sites* (2001) (106)
Proteomic analysis of coregulators bound to ERα on DNA and nucleosomes reveals coregulator dynamics. (2013) (106)
Effects of hormone and cellular modulators of protein phosphorylation on transcriptional activity, DNA binding, and phosphorylation of human progesterone receptors. (1992) (105)
Jun Dimerization Protein 2 Functions as a Progesterone Receptor N-Terminal Domain Coactivator (2002) (104)
Cyclin-Dependent Kinase Activity Is Required for Progesterone Receptor Function: Novel Role for Cyclin A/Cdk2 as a Progesterone Receptor Coactivator (2005) (103)
Progestin effects on breast cancer cell proliferation, proteases activation, and in vivo development of metastatic phenotype all depend on progesterone receptor capacity to activate cytoplasmic signaling pathways. (2007) (101)
A C619Y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1) (1999) (100)
Characterization and functional properties of the A and B forms of human progesterone receptors synthesized in a baculovirus system. (1991) (95)
Phosphorylation of human progesterone receptor by cyclin-dependent kinase 2 on three sites that are authentic basal phosphorylation sites in vivo. (1997) (94)
The steroid antagonist RU486 exerts different effects on the glucocorticoid and progesterone receptors. (1993) (92)
Generation of an in vitro 3D PDAC stroma rich spheroid model. (2016) (87)
Coregulatory proteins in steroid hormone receptor action: The role of chromatin high mobility group proteins HMG-1 and -2 (1999) (87)
Receptor mechanisms of rapid extranuclear signalling initiated by steroid hormones. (2004) (85)
Effects of estrogen and antiestrogen on DNA polymerase in human breast cancer. (1980) (84)
Steroid hormone-dependent interaction of human progesterone receptor with its target enhancer element. (1988) (83)
Progesterone receptor repression of prolactin/signal transducer and activator of transcription 5-mediated transcription of the beta-casein gene in mammary epithelial cells. (2007) (83)
Identification of phosphorylation sites unique to the B form of human progesterone receptor. In vitro phosphorylation by casein kinase II. (1994) (82)
Comparison of different antibodies for detection of progesterone receptor in breast cancer (2002) (80)
Progesterone receptor and the mechanism of action of progesterone antagonists (1995) (80)
Transcriptional response of the murine mammary gland to acute progesterone exposure. (2008) (78)
A quantitative comparison of dual control of a hormone response element by progestins and glucocorticoids in the same cell line. (1989) (78)
A germline variation in the progesterone receptor gene increases transcriptional activity and may modify ovarian cancer risk. (2004) (76)
The REGγ proteasome regulates hepatic lipid metabolism through inhibition of autophagy. (2013) (74)
Ligands induce conformational changes in the carboxyl-terminus of progesterone receptors which are detected by a site-directed antipeptide monoclonal antibody. (1992) (73)
Detection of a Mr 24,000 estrogen-regulated protein in human breast cancer by monoclonal antibodies. (1983) (73)
Human Progesterone Receptor Displays Cell Cycle-Dependent Changes in Transcriptional Activity (2005) (72)
Epigenetic Reprogramming of HOXC10 in Endocrine-Resistant Breast Cancer (2014) (72)
Mammary Stem Cells and Tumor-Initiating Cells Are More Resistant to Apoptosis and Exhibit Increased DNA Repair Activity in Response to DNA Damage (2015) (71)
Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. (1984) (68)
Immunologic analysis of human breast cancer progesterone receptors. 2. Structure, phosphorylation, and processing. (1987) (67)
Structural and functional analysis of domains of the progesterone receptor (2012) (67)
Minireview: dynamic structures of nuclear hormone receptors: new promises and challenges. (2014) (67)
The validation of new aromatase monoclonal antibodies for immunohistochemistry—A correlation with biochemical activities in 46 cases of breast cancer (2005) (67)
Structure of the progesterone receptor-deoxyribonucleic acid complex: novel interactions required for binding to half-site response elements. (2006) (66)
Identification of a group of Ser-Pro motif hormone-inducible phosphorylation sites in the human progesterone receptor. (1995) (66)
Hinge and amino-terminal sequences contribute to solution dimerization of human progesterone receptor. (1997) (66)
Inhibition of the hexosamine biosynthetic pathway promotes castration-resistant prostate cancer (2016) (65)
Erratum: Oncogenic mTOR signalling recruits myeloid-derived suppressor cells to promote tumour initiation (2016) (64)
16 alpha-substituted analogs of the antiprogestin RU486 induce a unique conformation in the human progesterone receptor resulting in mixed agonist activity. (1996) (63)
Lactogenic Hormonal Induction of Long Distance Interactions between β-Casein Gene Regulatory Elements* (2009) (63)
Progesterone receptor isoforms A and B differentially regulate MUC1 expression in uterine epithelial cells. (2006) (62)
A sequence in the 5′ flanking region confers progestin responsiveness on the human c-myc gene (1997) (62)
Human progesterone receptor binding to mouse mammary tumor virus deoxyribonucleic acid: dependence on hormone and nonreceptor nuclear factor(s). (1989) (62)
Heat shock alters the composition of heteromeric steroid receptor complexes and enhances receptor activity in vivo. (1992) (61)
The Role of the C-terminal Extension (CTE) of the Estrogen Receptor α and β DNA Binding Domain in DNA Binding and Interaction with HMGB* (2004) (60)
The C-terminal Extension (CTE) of the Nuclear Hormone Receptor DNA Binding Domain Determines Interactions and Functional Response to the HMGB-1/-2 Co-regulatory Proteins* (2002) (58)
Subcellular compartmentalization of estrogen receptors in human breast cancer cells. (1980) (57)
Progesterone receptor interacting coregulatory proteins and cross talk with cell signaling pathways (2002) (57)
Immunohistochemical detection of an estrogen-regulated protein by monoclonal antibodies. (1982) (57)
Phosphorylation and progesterone receptor function (1995) (56)
Phosphorylation of MNAR Promotes Estrogen Activation of Phosphatidylinositol 3-Kinase (2006) (56)
Coregulatory proteins in nuclear hormone receptor action. (1999) (55)
The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. (1998) (55)
Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer (2015) (55)
The 5'-flanking region of the ovine follicle-stimulating hormone-beta gene contains six progesterone response elements: three proximal elements are sufficient to increase transcription in the presence of progesterone. (1995) (55)
Progesterone receptor and Stat5 signaling cross talk through RANKL in mammary epithelial cells. (2013) (53)
Effects of the steroid antagonist RU486 on dimerization of the human progesterone receptor. (1992) (52)
Two Types of Anti-progestins Have Distinct Effects on Site-specific Phosphorylation of Human Progesterone Receptor (*) (1996) (50)
Monoclonal antibody storage conditions, and concentration effects on immunohistochemical specificity. (1983) (49)
Direct binding of progesterone receptor to nonconsensus DNA sequences represses rat GnRH (1996) (49)
Loss of MutL Disrupts CHK2-Dependent Cell-Cycle Control through CDK4/6 to Promote Intrinsic Endocrine Therapy Resistance in Primary Breast Cancer. (2017) (48)
The two faces of a steroid antagonist: When an antagonist isn't (1995) (47)
Immunocytochemical localization of progesterone receptors in breast cancer with anti-human receptor monoclonal antibodies. (1988) (47)
17α-Estradiol Is a Biologically Active Estrogen in Human Breast Cancer Cells in Tissue Culture* (1980) (46)
TRAF4‐mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis (2018) (45)
Design of homogeneous, monopegylated erythropoietin analogs with preserved in vitro bioactivity. (2006) (44)
Interaction of the progesterone receptor with binding proteins for FK506 and cyclosporin A. (1995) (44)
Progesterone receptor-induced bending of its target DNA: distinct effects of the A and B receptor forms. (1996) (44)
Validation of new aromatase monoclonal antibodies for immunohistochemistry: progress report (2003) (43)
Agonist and antagonists induce homodimerization and mixed ligand heterodimerization of human progesterone receptors in vivo by a mammalian two-hybrid assay. (1998) (43)
Regulation of the Amino-Terminal Transcription Activation Domain of Progesterone Receptor by a Cofactor-Induced Protein Folding Mechanism (2005) (43)
The antagonists RU486 and ZK98299 stimulate progesterone receptor binding to deoxyribonucleic acid in vitro and in vivo, but have distinct effects on receptor conformation. (1998) (42)
miR‐130b directly targets ARHGAP1 to drive activation of a metastatic CDC42‐PAK1‐AP1 positive feedback loop in Ewing sarcoma (2017) (39)
Comprehensive functional analysis of the tousled-like kinase 2 frequently amplified in aggressive luminal breast cancers (2016) (39)
Immunological detection of Chinese hamster ovary cells expressing a multidrug resistance phenotype. (1985) (39)
Progestins reinitiate cell cycle progression in antiestrogen-arrested breast cancer cells through the B-isoform of progesterone receptor. (2007) (38)
Differential Modulation of DNA Conformation by Estrogen Receptors α and β* (2002) (38)
TGF-β1 programmed myeloid-derived suppressor cells (MDSC) acquire immune-stimulating and tumor killing activity capable of rejecting established tumors in combination with radiotherapy (2018) (38)
Structural analysis of chicken oviduct progesterone receptor using monoclonal antibodies to the subunit B protein. (1984) (37)
Evidence that heat shock protein-70 associated with progesterone receptors is not involved in receptor-DNA binding. (1991) (37)
Validation Studies for Single Circulating Trophoblast Genetic Testing as a Form of Noninvasive Prenatal Diagnosis (2019) (37)
Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA (1994) (37)
Mechanisms of progesterone receptor inhibition of inflammatory responses in cellular models of breast cancer. (2010) (37)
Regulation of the Structurally Dynamic N-terminal Domain of Progesterone Receptor by Protein-induced Folding* (2013) (36)
Rapid extranuclear signaling by the estrogen receptor (ER): MNAR couples ER and Src to the MAP kinase signaling pathway. (2003) (35)
Wild-Type N-Ras, Overexpressed in Basal-like Breast Cancer, Promotes Tumor Formation by Inducing IL-8 Secretion via JAK2 Activation. (2015) (35)
Mechanisms controlling agonist and antagonist potential of selective progesterone receptor modulators (SPRMs). (2005) (35)
Mass Spectrometry-Based Proteomics Reveals Potential Roles of NEK9 and MAP2K4 in Resistance to PI3K Inhibition in Triple-Negative Breast Cancers. (2018) (34)
Purification of an estrogen-regulated breast cancer protein by monoclonal antibody affinity chromatography. (1983) (34)
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer (2018) (34)
Failure of estradiol immunofluorescence in MCF-7 breast cancer cells to detect estrogen receptors. (1981) (33)
Differential Phosphorylation of Perilipin 1A at the Initiation of Lipolysis Revealed by Novel Monoclonal Antibodies and High Content Analysis (2013) (31)
Progesterone receptor directly inhibits β-casein gene transcription in mammary epithelial cells through promoting promoter and enhancer repressive chromatin modifications. (2011) (31)
Stoichiometry and Site-specific Phosphorylation of Human Progesterone Receptor in Native Target Cells and in the Baculovirus Expression System* (1996) (31)
A Progesterone Receptor Co-activator (JDP2) Mediates Activity through Interaction with Residues in the Carboxyl-terminal Extension of the DNA Binding Domain♦ (2009) (30)
Mechanism of high-mobility group protein B enhancement of progesterone receptor sequence-specific DNA binding (2008) (30)
Estrogen regulation of specific messinger RNA's in human breast cancer cells. (1980) (29)
A 361 base pair region of the rat FSH-β promoter contains multiple progesterone receptor-binding sequences and confers progesterone responsiveness (1997) (28)
Evaluation of the Virus Counter® for rapid baculovirus quantitation. (2011) (28)
Novel Mechanisms of Progesterone Antagonists and Progesterone Receptor (2000) (27)
Human placental 3beta-hydroxysteroid dehydrogenase: delta5-isomerase. Demonstration of an intermediate in the conversion of 3beta-hydroxypregn-5-en-20-one to pregn-4-ene-3,20-dione. (1976) (26)
Progestin stimulation of manganese superoxide dismutase and invasive properties in T47D human breast cancer cells (2009) (26)
Binding of [3H]progesterone to the human progesterone receptor: differences between individual and mixed isoforms. (1996) (26)
The presence of an estrogen-regulated protein detected by monoclonal antibody in abnormal human endometrium. (1985) (26)
Mammary Precancerous Stem and Non-Stem Cells Evolve into Cancers of Distinct Subtypes. (2018) (26)
Influence of domain interactions on conformational mobility of the progesterone receptor detected by hydrogen/deuterium exchange mass spectrometry. (2014) (25)
The oncogenic STP axis promotes triple-negative breast cancer via degradation of the REST tumor suppressor. (2014) (23)
Mechanisms controlling steroid receptor binding to specific DNA sequences (1991) (23)
Partial agonist activity of the progesterone receptor antagonist RU486 mediated by an amino-terminal domain coactivator and phosphorylation of serine400. (2010) (23)
The role of the C-terminal extension (CTE) of the estrogen receptor alpha and beta DNA binding domain in DNA binding and interaction with HMGB. (2004) (23)
Binding-Folding Induced Regulation of AF1 Transactivation Domain of the Glucocorticoid Receptor by a Cofactor That Binds to Its DNA Binding Domain (2011) (23)
Estradiol stimulates synthesis of a major intracellular protein in a human breast cancer cell line (MCF-7) (2005) (23)
Consequences of early postnatal lipopolysaccharide exposure on developing lungs in mice. (2019) (22)
Specific protein synthesis regulated by estrogen in human breast cancer. (1981) (21)
Molecular cloning of a cDNA for the chicken progesterone receptor B antigen. (1984) (20)
Estrogen regulation of growth and specific protein synthesis in human breast cancer cells in tissue culture. (1981) (20)
Systemic distribution of progesterone receptor subtypes in human tissues (2020) (20)
17 alpha-Estradiol is a biologically active estrogen in human breast cancer cells in tissue culture. (1980) (19)
Estrogen regulation of specific proteins as a mode of hormone action in human breast cancer. (1983) (18)
Elevated nuclear expression of the SMRT corepressor in breast cancer is associated with earlier tumor recurrence (2012) (18)
Modulators of cellular protein phosphorylation alter thetrans-activation function of human progesterone receptor and the biological activity of progesterone antagonists (2004) (17)
The Germ Cell Gene TDRD1 as an ERG Target Gene and a Novel Prostate Cancer Biomarker (2016) (16)
Monoclonal Antibodies Specific for STAT3β Reveal Its Contribution to Constitutive STAT3 Phosphorylation in Breast Cancer (2014) (16)
Differential Regulation of Progesterone Receptor-Mediated Transcription by CDK2 and DNA-PK. (2016) (15)
Immunologic detection of a protein homologous to chicken progesterone receptor B subunit. (1985) (15)
An immunotoxin cytotoxic for breast cancer cells in vitro. (1987) (15)
Finally! A model for progesterone receptor action in normal human breast. (2009) (15)
Differential modulation of DNA conformation by estrogen receptors alpha and beta. (2002) (14)
A new mild hyperthermia device to treat vascular involvement in cancer surgery (2017) (14)
Methylseleninic acid is a novel suppressor of aromatase expression. (2012) (14)
The Progestin Receptor Interactome in the Female Mouse Hypothalamus: Interactions with Synaptic Proteins Are Isoform Specific and Ligand Dependent (2017) (13)
Synthesis and antiprogestational properties of novel 17-fluorinated steroids (2013) (13)
Progesterone and regulation of the follicle-stimulating hormone (FSH-β) gene (1999) (13)
Estrogen action in human breast cancer (review). (1982) (12)
NEMO, a Transcriptional Target of Estrogen and Progesterone, Is Linked to Tumor Suppressor PML in Breast Cancer. (2017) (12)
Cyclin A2 and its associated kinase activity are required for optimal induction of progesterone receptor target genes in breast cancer cells (2014) (10)
Expression and purification of recombinant human progesterone receptor in baculovirus and bacterial systems. (2001) (10)
UCHL1 loss alters the cell-cycle in metastatic pancreatic neuroendocrine tumors. (2019) (10)
Hormone Action in Human Breast Cancer Estrogen Regulation of Specific Proteins (1983) (9)
The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast (2018) (8)
Estrogen-induced 24K protein in MCF-7 breast cancer cells is localized in granules (2005) (8)
The requirement for p42/p44 MAPK activity in progesterone receptor-mediated gene regulation is target gene-specific (2013) (7)
Erratum: A c619y mutation in the human androgen receptor causes inactivation and mislocalization of the receptor with concomitant sequestration of SRC-1 (steroid receptor coactivator 1) (Molecular Endocrinology (1999) 13 (2065-2075)) (2000) (7)
Estrogen-regulated protein in human breast cancer. (1984) (6)
Localizing steroid dehydrogenase activity on acrylamide gels: the perils of "histochemistry". (1977) (6)
Progesterone and regulation of the follicle-stimulating hormone (FSH-beta) gene. (1999) (6)
A role for site-specific phosphorylation of mouse progesterone receptor at serine 191 in vivo. (2014) (6)
Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration. (2021) (6)
Proteomic Resistance Biomarkers for PI3K Inhibitor in Triple Negative Breast Cancer Patient-Derived Xenograft Models (2020) (6)
Monoclonal antibodies to human medulloblastoma cell line te671 reactivity in neuroectodermal cell lines and tumors (1985) (5)
Use of HCA in subproteome-immunization and screening of hybridoma supernatants to define distinct antibody binding patterns. (2016) (5)
A mouse model engineered to conditionally express the progesterone receptor‐B isoform (2018) (5)
Immunoaffinity Purification and Structural Analysis of Human Breast Cancer Progesterone Receptors (1987) (5)
Mapping contacts between unpurified human progesterone receptor and the hormone response element of mouse mammary tumor virus. (1989) (5)
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression (2020) (5)
STRUCTURE OF THE PROGESTERONE RECEPTOR-DNA COMPLEX (2006) (5)
Progesterone Receptor Structure/Function and Crosstalk with Cellular Signaling Pathways (2003) (5)
SSTR5 P335L monoclonal antibody differentiates pancreatic neuroendocrine neuroplasms with different SSTR5 genotypes. (2011) (4)
Mass spectrometry-based proteomics reveals potential roles of NEK9 and MAP2K4 in resistance to PI3K inhibitors in triple negative breast cancers (2018) (4)
Progesterone receptor isoform B expression in pulmonary neuroendocrine cells decreases cell proliferation (2019) (4)
Different populations of progesterone receptor–steroid complexes in binding to specific DNA sequences: effects of salts on kinetics and specificity (1998) (4)
BCL9/STAT3 regulation of transcriptional enhancer networks promote DCIS progression (2020) (3)
Reverse-Phase Protein Array: Technology, Application, Data Processing, and Integration. (2021) (3)
Reverse Phase Protein Array Reveals Correlation of Retinoic Acid Metabolism With Cardiomyopathy in Friedreich's Ataxia (2021) (3)
Inhibition of human placental progesterone synthesis by estranes: a novel relationship of structure to activity. (1977) (3)
Chapter 14 Progesterone action and receptors (1988) (3)
TRAF 4-mediated ubiquitination of NGF receptor TrkA regulates prostate cancer metastasis (2018) (3)
Monoclonal antibody characterization of a breast cancer associated 43000 dalton membrane glycoprotein (1985) (2)
Differential regulation of the progesterone receptor (PR) by TCDD in isolated human endometrial stromal cells versus stromal-epithelial co-cultures (2002) (2)
Conformational Changes of RORγ During Response Element Recognition and Coregulator Engagement. (2021) (2)
High-throughput profiling of histone post-translational modifications and chromatin modifying proteins by reverse phase protein array. (2022) (2)
Immunologies! Detection of Chinese Hamster Ovary Cells Expressing a Multidrug Resistance Phenotype1 (1985) (1)
A monoclonal antibody produced against the chicken oviduct progesterone receptor shows cross reaction with human antigen (1984) (1)
Abstract P4-04-01: Loss of mismatch repair predicts resistance to endocrine therapy and sensitivity to CDK4/6 inhibitors in ER+ breast cancer (2018) (1)
The Prognostic Impact of Intratumoral Aryl Hydrocarbon Receptor in Primary Breast Cancer Depends on the Type of Endocrine Therapy: A Population-Based Cohort Study (2021) (1)
Failure of Estradici Immunofluorescence in MCF-7 Breast Cancer Cells to Detect Estrogen Receptors 1 Wayne 0 (2006) (1)
Estrogen Regulation of Specific Proteins (1983) (1)
Progesterone Receptor Repression of Prolactin/Stat5-Mediated Transcription of the β-Casein Gene in Mammary Epithelial Cells (2006) (1)
Upregulation of EGFR signaling is correlated with tumor stroma remodeling and tumor recurrence in FGFR1-driven breast cancer (2015) (1)
Phosphorylation of MNAR Promotes Estrogen Activation of PI3 Kinase (2006) (1)
Studies with Monoclonal Antibodies to Breast Tumors (1985) (1)
Abstract PD2-04: FOXA1 induces a pro-metastatic secretome through ER-dependent and independent transcriptional reprogramming in endocrine-resistant breast cancer (2017) (1)
Protein by monoclonal antibodies. (1982) (1)
Monoclonal antibody characterization of a tumor-associated breast cancer antigen. (1986) (1)
Phosphorylation/Dephosphorylation regulates the activity of progesterone receptors (1993) (1)
Abstract P3-05-13: Overexpression of insulin receptor substrate 4 can mediate acquired resistance to lapatinib-containing regimens in HER2+ breast cancer cells (2015) (1)
3C. 3-Ketosteroid receptors (version 2019.4) in the IUPHAR/BPS Guide to Pharmacology Database (2019) (1)
Abstract 2139: Wild type N-Ras, overexpressed in basal-like breast cancer, promotes tumor formation by inducing IL8 secretion via JAK2 activation (2015) (0)
Abstract 1084: TRAF4-mediated NGF receptor TrkA ubiquitination regulates prostate cancer metastasis (2018) (0)
High-Throughput Evaluation of Metabolic Activities Using Reverse Phase Protein Array Technology (2021) (0)
341 Characterization of a 24K estrogen regulated protein in human breast cancer cells (1983) (0)
Metformin inhibits stromal aromatase expression and tumor progression in a rodent model of postmenopausal breast cancer (2018) (0)
Phosphorylation of MNAR Promotes Estrogen Activation of Phosphatidylinositol 3-Kinase (2010) (0)
Abstract 930: Production of functionally active recombinant FOXA1: The first step towards targeted drug discovery (2021) (0)
Tu1273 - Expression of Constitutively Active Mitogen-Activated Protein Kinase 1 (MEK1) Profoundly Disrupts Ileal Epithelial Homeostasis (2018) (0)
SUN-742 Roles of Progesterone Receptor Isoform B in Non-Small Cell Lung Cancer Tumor Progression (2020) (0)
3C. 3-Ketosteroid receptors in GtoPdb v.2021.3 (2021) (0)
Mono clonal antibodies to mammary carcinoma membrane proteins generated by in vitro immunization (1983) (0)
Human Progesterone Receptor Crosstalk with Cytoplasmic Signaling Molecules Through Direct SH3 Domain Interaction (2003) (0)
Ph.D. Post-Doctoral Training Program in Breast Cancer Research (2002) (0)
Abstract B01: B cell lymphoma 9 mediates a cross talk between the canonical Wnt and EGFR signaling in breast cancer (2016) (0)
Abstract P1-07-07: Recurrent ESR1-CCDC170 rearrangements in an aggressive subset of estrogen-receptor positive breast cancers (2015) (0)
Facilitated Binding of Steroid Hormone Receptors to Target DNA by the Chromatin High-Mobility Group Protein-1: Protein Manipulation of DNA Structure (1997) (0)
Abstract 3032: Genomic deregulation and therapeutic role of the cell-cycle kinase TLK2 in more aggressive breast cancers (2015) (0)
Antibodies in Breast Cancer with Anti-Human Receptor Monoclonal Immunocytochemical Localization of Progesterone Receptors Updated (2006) (0)
Progesterone receptors in breast cancer. (1992) (0)
Abstract P6-05-12: Lack of Frequent Estrogen Receptor Mutation in Primary Breast Tumors (2012) (0)
Abstract 1056: Inhibition of hexose monophosphate pathway promotes castration resistant prostate cancer (2016) (0)
Cover Image, Volume 56, Issue 8 (2018) (0)
AWARD NUMBER: W81XWH-14-1-0326 TITLE: Overcoming Endocrine Resistance by Targeting ER/FoxA1/IL-8 Axis PRINCIPAL INVESTIGATOR: Xiaoyong Fu CONTRACTING ORGANIZATION: Baylor College of Medicine (2016) (0)
Abstract 489: Mismatch repair defects and endocrine therapy resistance in estrogen receptor positive breast cancer (2017) (0)
Effects of Estrogen and Antiestrogen on DMA Polymerase in Human Breast Cancer (2006) (0)
Correction to: The Emerging Roles of Steroid Hormone Receptors in Ductal Carcinoma in Situ (DCIS) of the Breast (2018) (0)

This paper list is powered by the following services:

What Schools Are Affiliated With Dean Paul Edwards?

Dean Paul Edwards is affiliated with the following schools:

Dean Paul Edwards's Academic­Influence.com Rankings

Dean Paul Edwards's Degrees

Why Is Dean Paul Edwards Influential?

Dean Paul Edwards's Published Works

Published Works

What Schools Are Affiliated With Dean Paul Edwards?

Dean Paul Edwards's AcademicInfluence.com Rankings